Human Papillomavirus

Part of the Clinical Perspectives in Obstetrics and Gynecology book series (CPOG)


Fewer topics in obstetrics and virology will generate stronger opinions backed only by anecdotal data than the issue of human papillomavirus (HPV) infection during pregnancy. Any effort to address the topic of management of the pregnant patient with genital HPV must confront the vast literature from virologists, epidemiologists, obstetrician-gynecologists, dermatologists, and ears, nose, and throat specialists, each with its particular medical and philosophic bias. Few consensus opinions among these diverse disciplines exist, although most would agree that (1) HPV genital infections in women (and men) have increased dramatically in the past two decades, (2) our ability to detect smaller amounts of HPV DNA continues to improve, and (3) laryngeal papillomatosis (by far the worst neonatal “outcome” of maternal HPV infection) is an uncommon but potentially devastating problem best treated by prevention, if possible. The situation has become more complicated by the inevitable arrival of personal injury attorneys seeking damages for nonprevention of laryngeal papillomatosis by failure to perform prophylactic cesarean section in women with genital HPV infection. In addition, some effective therapies for HPV are medically contrain- dicated during pregnancy because of theoretical adverse fetal effects, thereby limiting our available “arsenal” against this agent.


Human Papilloma Virus Obstet Gynecol Genital Tract Lower Genital Tract Clin Obstet Gynecol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Danos O, Engel LW, Chen EY, Yaniv M, Howley PM. Comparative analysis of the human type la and bovine type 1 papilloma-virus genomes. J Virol. 1983; 46: 557–566.PubMedGoogle Scholar
  2. 2.
    Kurman RJ, Shiffman RM, Lancaster WD, et al. Analysis of individual human papillomavirus types in cervical neoplasia: A possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988; 159: 293–296.PubMedGoogle Scholar
  3. 3.
    Stone KM. Epidemiologic aspects of genital HPV infection. Clin Obstet Gynecol 1989; 1: 112–116.Google Scholar
  4. 4.
    Bernstein SG, Voet RL, Guzick DS, et al. Prevalence of papillomavirus infection in col- poscopically directed cervical biopsy specimens in 1972 and 1982. Am J Obstet Gynecol 1985; 151: 577–581.PubMedGoogle Scholar
  5. 5.
    Becker TM, Stone KM, Alexander ER. Genital human papillomavirus infection. Obstet Gynecol Clin North Am. 1987; 14: 389–397.PubMedGoogle Scholar
  6. 6.
    Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer. 1987; 40: 198–201.PubMedCrossRefGoogle Scholar
  7. 7.
    Rando RF, Lindheim S, Hasty L, et al. Increased frequency of detection of human papillomavirus DNA in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 1989; 161: 50–55.PubMedGoogle Scholar
  8. 8.
    Kemp EA, Hakenwerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992; 79: 649–656.PubMedGoogle Scholar
  9. 9.
    Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, eds. Cancer Cells 7: Molecular Diagnostics of Human Cancer. New York: Cold Spring Harbor Laboratory Press; 1989: 209–214.Google Scholar
  10. 10.
    Greennberg H, Mann WJ, Chumas J, Zuna R, Patsner B. Cervical and vaginal pathology in women with vulvar condylomata. J Reprod Med. 1987; 32: 801–804.Google Scholar
  11. 11.
    Stoler MH, Broker TR. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol. 1986; 17: 1250–1258.PubMedCrossRefGoogle Scholar
  12. 12.
    Ferenczy A. HPV-associated lesions in pregnancy and their clinical implications. Clin Obstet Gynecol 1989; 32: 191–199.PubMedCrossRefGoogle Scholar
  13. 13.
    Kirchner H. Immunobiology of human papil-lomavirus infection. Prog Med Virol. 1986; 33: 1–41.PubMedGoogle Scholar
  14. 14.
    Goldschmidt H, Kingman AM. Experimental inoculation of humans with ectodermotropic viruses. J Invest Dermatol. 1958; 31: 175–182.PubMedGoogle Scholar
  15. 15.
    National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervi-cal/vaginal cytologic diagnoses. JAMA. 1988; 262: 931.Google Scholar
  16. 16.
    Young RL, Acosta A, Kaufman RH. The treatment of large condylomata acuminata complicating pregnancy. Obstet Gynecol. 1973; 41: 65–73.PubMedGoogle Scholar
  17. 17.
    Ullman EV. On the etiology of the laryngeal papilloma. Acta Otolaryngol. 1923; 5: 317.Google Scholar
  18. 18.
    Quick CA, Watts SL, Krzyzek RA, et al. Relationship between condylomata and laryngeal papillomata: Clinical and molecular virological evidence. Ann Otol Rhinol Laryngol. 1980; 89: 467.PubMedGoogle Scholar
  19. 19.
    Nikolaidis ET, Trost DC, Bucholz CL, Wilkinson E J. The relationship of histologic and clinical factors in laryngeal papillomatosis. Arch Pathol Lab Med. 1985; 109: 24.PubMedGoogle Scholar
  20. 20.
    Kreider J, Howett MK, Stoler MH, Zaine R, Welsh P. Susceptibility of various tissues to transformation in vivo with human papil-lomavirus type 11. Int J Cancer. 1987; 39: 459.PubMedCrossRefGoogle Scholar
  21. 21.
    Mounts P, Shah KV. Respiratory papillomatosis: Etiological relation to genital tract papillomaviruses. Prog Med Virol. 1984; 29: 90–114.PubMedGoogle Scholar
  22. 22.
    Roman A, Fife K. Human papillomavirus DNA associated foreskins of normal new-borns. J Infect Dis. 1986; 153: 855.PubMedCrossRefGoogle Scholar
  23. 23.
    McDonnell PJ, McDonnell JM, Kessis T, Green WR, Shah KV. Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hydridization with radioactive probes. Hum Pathol. 1987; 18: 1115.PubMedCrossRefGoogle Scholar
  24. 24.
    Tang CK, Shermeta DW, Wood C. Congenital condylomata acuminata. Am J Obstet Gynecol. 1978;131:912. Bruce Patsner, David A. Baker, and Earl JackmanGoogle Scholar
  25. 25.
    Fleming KA, Venning V, Evans M. DNA typing of genital warts and diagnosis of sexual abuse of children. Lancet. 1987; 2: 454.PubMedCrossRefGoogle Scholar
  26. 26.
    Shah K, Kashima H, Polk BF, et al. Rarity of cesarean delivery in cases of juvenile onset respiratory papillomatosis. Obstet Gynecol. 1986; 68: 795–799.PubMedGoogle Scholar
  27. 27.
    Smith EM, Johnson SR, Cripe TR, Pignatari S, Turek L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol. 1991; 100: 479–483.PubMedGoogle Scholar
  28. 28.
    Patsner B, Baker DA, Orr JW Jr. Human papillomavirus genital tract infections during pregnancy. Clin Obstet Gynecol. 1990; 33: 258–267.PubMedCrossRefGoogle Scholar
  29. 29.
    Sedlacek TV, Lindheim S, Eder C, et al. Mechanism for human papillomavirus transmission at birth. Am J Obset Gynecol. 1989; 161: 55–59.Google Scholar
  30. 30.
    Chriastiansen PL, Jorgensen K, Gontued A. Juvenile papillomatosis of the larynx. Acta Otolaryngol. 1984; 412 (suppl): 37.Google Scholar
  31. 31.
    Lindbergh H, Elbrond 0. Laryngeal papillo-mas: The epidemiology in a Danish subpopulation 1965-84. Clin Otolaryngol. 1990;15:125– 131.Google Scholar
  32. 32.
    Purola E, Savia E. Cytology of gynecologic condyloma acuminatum. Acta Cytol. 1977; 21: 26–31.PubMedGoogle Scholar
  33. 33.
    Schneider A. Methods of identification of human papillomaviruses. In: Syrjanen K, Gissman L, Koss LG, eds. Papillomaviruses and Human Disease. Berlin: Springer-Verlag; 1987; 19–39.Google Scholar
  34. 34.
    Riva JM, Sedlacek TV, Cunnane MF, Mangan CE. Extended carbon dioxide laser vaporization in the treatment of subclinical papillomavirus infection of the lower genital tract. Obstet Gynecol. 1989; 73: 25–30.PubMedGoogle Scholar
  35. 35.
    Wilson J. Extensive vulvar condylomata acuminata necessitating cesarean section. Aust NZJ Obstet Gynaecol. 1973; 13: 121–124.CrossRefGoogle Scholar
  36. 36.
    Ling MR. Therapy of genital human papil-lomavirus infections. Part II. Method of treatment. Int J Dermatol. 1992; 31: 769–776.PubMedCrossRefGoogle Scholar
  37. 37.
    Krebs HB. The use of topical five-fluorouracil in the treatment of genital condylomas. Obstet Gynecol Clin North Am. 1987; 14: 559.PubMedGoogle Scholar
  38. 40.
    Slater GE, Rumack BH, Peterson RG. Podophyllin poisoning: Systemic toxicity following cutaneous application. Obstet Gynecol. 1978; 52: 94–95.PubMedGoogle Scholar
  39. 41.
    Reid R, Greenberg MD. Human papilloma- virus-related diseases of the vulva. Clin Obstet Gynecol 1991; 34: 630–650.PubMedCrossRefGoogle Scholar
  40. 42.
    Ferenczy A. Treating genital condyloma during pregnancy with the carbon dioxide laser. Am J Obstet Gynecol 1984; 148: 9–12.PubMedGoogle Scholar
  41. 43.
    Rader JS, Leake JF, Dillon MB, Rosenshein NB. Ultrasonic surgical aspiration in the treatment of vulvar disease. Obstet Gynecol 1991; 77: 573–576.PubMedGoogle Scholar
  42. 44.
    Schwartz DB, Greenberg MD, Daoud Y, Reid R. Genital condylomas in pregnancy: Use of trichloroacetic acid and laser therapy. Am J Obstet Gynecol 1988; 158: 1407–1416.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

There are no affiliations available

Personalised recommendations